Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

CAPS Rating: 4 out of 5

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

Recs

1
Player Avatar KirkDCJ (< 20) Submitted: 2/23/2011 12:02:25 PM : Outperform Start Price: $13.20 MNTA Score: +3.28

Cheap at the price with room to run.

Featured Broker Partners


Advertisement